Combination Therapy Of Substituted Oxazolidinones
    3.
    发明申请
    Combination Therapy Of Substituted Oxazolidinones 审中-公开
    取代的恶唑烷酮的组合​​治疗

    公开(公告)号:US20160303138A1

    公开(公告)日:2016-10-20

    申请号:US15190944

    申请日:2016-06-23

    摘要: The present invention relates to combinations of A) oxazolidinones of the formula (I) with B) acetylsalicylic acid (aspirin) and C) an ADP receptor antagonist, in particular P2Y12 purinoreceptor blocker, to a process for producing these combinations and to the use thereof as medicaments, in particular for the prophylaxis and/or treatment of thromboembolic disorders.

    摘要翻译: 本发明涉及式(I)的A)恶唑烷酮与B)乙酰水杨酸(阿司匹林)和C)ADP受体拮抗剂,特别是P2Y12嘌呤受体阻断剂的组合,涉及制备这些组合的方法及其用途 作为药物,特别是用于预防和/或治疗血栓栓塞障碍。